Jacobs Engineering Group Inc (JEC) 51.47 $JEC Jacobs

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Jacobs Engineering Group Inc (JEC) 51.47 $JEC

Jacobs (JEC) Obtains BAYQIK Technology Patent from Bayer
Zacks Equity Research - Zacks Investment Research - Thu Sep 01, 9:05AM CDT
Jacobs Engineering Group Inc. (JEC) recently revealed that it has obtained the patented rights of Bayer AG???s (BAYRY) BAYQIK quasi-isothermal sulfuric acid converter and other associated technology.
BCC: 26.31 (-0.10), JEC: 51.47 (-0.78), WLDN: 18.05 (+0.09)

Jacobs Acquires BAYQIK(R) Sulfuric Acid Converter Technology from Bayer AG
BusinessWire - Wed Aug 31, 6:45AM CDT
Jacobs Engineering Group Inc. (NYSE:JEC) announced today it acquired the patent rights for BAYQIK(R) quasi-isothermal sulfuric acid converter technology and other related technology from Bayer AG.
JEC: 51.47 (-0.78)

NCI Building (NCS) Q3 Earnings: Can the Stock Surprise?
Zacks Equity Research - Zacks Investment Research - Thu Aug 25, 8:24AM CDT
NCI Building (NCS) will report its third quarter fiscal 2016 results on Aug 30.
JEC: 51.47 (-0.78), NCS: 14.65 (-0.37), LII: 161.41 (-1.75), LPX: 20.00 (-0.03)

Jacobs (JEC) to Boost Energy Business on TransCanada Deal
Zacks Equity Research - Zacks Investment Research - Thu Aug 25, 4:44AM CDT
Renowned technical services company Jacobs Engineering Group Inc. (JEC) lately inked a three-year deal with the premium North American energy infrastructure company, TransCanada Corporation (TRP).
BCC: 26.31 (-0.10), JEC: 51.47 (-0.78), TRP: 46.98 (+0.29), WLDN: 18.05 (+0.09)

Stock Market News for August 24, 2016
Zacks Equity Research - Zacks Investment Research - Wed Aug 24, 8:56AM CDT
Upbeat new-home sales data and better-than-expected European private sector data led the benchmarks to close in the green on Tuesday
JEC: 51.47 (-0.78), MDT: 86.85 (-0.47), MON: 108.02 (+0.58), PFE: 34.88 (+0.11), TREE: 91.78 (-3.91), FCX: 10.62 (+0.14), MRKT: 32.84 (+0.18), MYL: 40.16 (+0.19), BBY: 38.40 (-0.35), LEN: 46.29 (-0.27), AA: 10.17 (+0.04), CF: 25.68 (-0.26), KBH: 15.21 (-0.15), MTH: 35.69 (-0.28), TOL: 30.66 (-0.06), INTU: 110.89 (-1.18)

Jacobs Secures Engineering Services Agreement with TransCanada
BusinessWire - Wed Aug 24, 6:45AM CDT
Jacobs Engineering Group Inc. (NYSE:JEC) announced today it signed a three-year master engineering services agreement with TransCanada Corporation (TSX:TRP) (NYSE:TRP) (TransCanada), a leading energy infrastructure company in North America.
JEC: 51.47 (-0.78), TRP: 46.98 (+0.29), TRP.TO: 60.27 (-0.39)

Jacobs Wins Pfizer's Chinese Bio-Facility Project Contract
Zacks Equity Research - Zacks Investment Research - Wed Aug 24, 5:32AM CDT
Jacobs Engineering Group Inc. (JEC) joined hands with Pfizer Inc. (PFE) for developing a new Chinese state-of-the-art biotechnology centre.
JEC: 51.47 (-0.78), PFE: 34.88 (+0.11), AWI: 43.44 (-0.20), WLDN: 18.05 (+0.09)

Jacobs Awarded Design Contract for Pfizer Global Biotechnology Center in China
BusinessWire - Tue Aug 23, 6:45AM CDT
Jacobs Engineering Group Inc. (NYSE:JEC) announced today it was awarded a contract to lead design and provide engineering services, procurement and construction support for Pfizer, Inc.'s new $350 million Global Biotechnology Center investment in the Hangzhou Economic Development Area in China.
JEC: 51.47 (-0.78)

Jacobs Wins Further Contract for Highways England's Roads Investment Program
BusinessWire - Tue Aug 16, 6:45AM CDT
Jacobs Engineering Group Inc (NYSE:JEC) announced today its appointment by Highways England to develop preferred options for multiple highways schemes planned in the east, southeast and northwest regions of England, United Kingdom.
JEC: 51.47 (-0.78)

Downgrade Alert for Jacobs Engineering Group (JEC)
Comtex SmarTrend(R) - Fri Aug 12, 3:16AM CDT
Jacobs Engineering Group (NYSE:JEC) was downgraded from Accumulate to Hold at Johnson Rice today. The stock closed yesterday at $54.41 on volume of 1.2 million shares, above average daily volume of 745,000. Over the past year, Jacobs Engineering Group has traded in a range of $34.76 to $55.89 and closed yesterday at $54.41, 57% above that low. The 200-day and 50-day moving averages have moved 0.24% higher and 1.31% higher over the past week, respectively.
JEC: 51.47 (-0.78)

Jacobs Awarded Contract for Novartis Biotechnology Center Expansion in France
BusinessWire - Thu Aug 11, 6:45AM CDT
Jacobs Engineering Group Inc. (NYSE:JEC) announced today it was awarded a contract to expand the Novartis Pharma S.A.S. Biotechnology Center in Huningue, France.
JEC: 51.47 (-0.78)

AECOM (ACM) Tops Q3 Earnings, Lags Revenues; View Intact
Zacks Equity Research - Zacks Investment Research - Wed Aug 10, 8:19AM CDT
AECOM???s (ACM) adjusted earnings per share for third-quarter fiscal 2016 came in at 81 cents, which surpassed the Zacks Consensus Estimate of 71 cents.
JEC: 51.47 (-0.78), ACM: 30.27 (-0.39), WLDN: 18.05 (+0.09), AOS: 96.37 (-0.61)

Jacobs Awarded Transformation Contract with UK Ministry of Defence
BusinessWire - Wed Aug 10, 6:45AM CDT
Jacobs Engineering Group Inc. (NYSE:JEC) announced today it received a contract from the U.K. Ministry of Defence (MOD) to provide technical support to the Service Provision and Transformation Contract associated with the MOD's Strategic Support Supplier Project (SSS) for land equipment use in the United Kingdom.
JEC: 51.47 (-0.78)

SmarTrend Watching for Potential Pullback in Shares of Jacobs Engineering Group After 4.46% Gain
Comtex SmarTrend(R) - Tue Aug 09, 3:09PM CDT
Jacobs Engineering Group (NYSE:JEC) traded in a range yesterday that spanned from a low of $53.53 to a high of $55.89. Yesterday, the shares gained 4.5%, which took the trading range above the 3-day high of $54.38 on volume of 576,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
JEC: 51.47 (-0.78)

After Yesterday's Rally of 4.46% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Tue Aug 09, 3:07PM CDT
Jacobs Engineering Group (NYSE:JEC) traded in a range yesterday that spanned from a low of $53.53 to a high of $55.89. Yesterday, the shares gained 4.5%, which took the trading range above the 3-day high of $54.38 on volume of 576,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
JEC: 51.47 (-0.78)

Jacobs (JEC) Earnings Top, Revenues Lag Estimates in Q3
Zacks Equity Research - Zacks Investment Research - Tue Aug 09, 9:46AM CDT
Jacobs Engineering Group Inc. (JEC) posted adjusted earnings (excluding after-tax costs related to certain restructuring activities) of 78 cents per share in the third quarter of fiscal 2016.
JEC: 51.47 (-0.78), ACM: 30.27 (-0.39), WLDN: 18.05 (+0.09), AOS: 96.37 (-0.61)

Jacobs Engineering Group (JEC) Approaches New Upside Target of $54.77
Comtex SmarTrend(R) - Tue Aug 09, 8:52AM CDT
Jacobs Engineering Group (NYSE:JEC) has opened bullishly above the pivot of $53.69 today and has reached the first level of resistance at $54.08. Should the shares continue to rise, the resistance pivots of $54.77 and $55.85 will be of interest.
JEC: 51.47 (-0.78)

Jacobs (JEC) Beats on Q3 Earnings, Misses Revenues
Zacks Equity Research - Zacks Investment Research - Tue Aug 09, 7:25AM CDT
Jacobs Engineering Group Inc. (JEC) reported adjusted earnings per share of 78 cents, up 5.4% with respect to the Zacks Consensus Estimate of 74 cents.
JEC: 51.47 (-0.78)

Jacobs Engineering Group Inc. Reports Earnings for the Third Quarter of Fiscal 2016
BusinessWire - Tue Aug 09, 5:45AM CDT
Jacobs Engineering Group Inc. (NYSE:JEC) today announced its financial results for the third quarter of fiscal 2016 ended July 1, 2016.
JEC: 51.47 (-0.78)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 63

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
Motphys Unleashes MotrixSim 1.0, Aiming at Simulation Dominance

Updated Category News Views 234

Motphys Breaks into the Global Simulation Scene The tech world just got slammed with what might be a seismic shift: Motphys, a bold outfit hailing from China, has dropped its brand-new, homegrown simulation engine, MotrixSim 1.0. It's causing quite the stir, unveiling at the Conference on Robot Learning 2026 (CoRL) and throwing down the gauntlet to Western titans like...

Continue Reading
Greenberg Traurig's Brad Kaufman: A Mentor of Resolute Impact

Updated Category News Views 315

A Milestone for Mentorship at Greenberg Traurig In the often cutthroat jungle of law, finding someone who actually gives a damn about you is as rare as finding a unicorn. Yet, there it is—Brad Kaufman, at the helm of Greenberg Traurig's professional development, proving that mentorship can be more than just a checkbox on a quarterly review. Award for Exceptional...

Continue Reading
Manhattan Associates Faces Investigation by KSF Law Firm

Updated Category News Views 219

KSF Digs Into Manhattan Associates' Claims In the swirl of the financial world, you rarely see an investigation that doesn’t raise a few eyebrows. This time, it's Manhattan Associates, Inc. (NasdaqGS: MANH) squarely in the crosshairs of Kahn Swick & Foti, LLC (KSF), a pivotal player in securities litigation. You’ve got to wonder what dirt might be uncovered here,...

Continue Reading
MV Transportation Celebrates Leadership Nomination for FTA

Updated Category News Views 174

MV Throws Support Behind Aesch for FTA Role In this wild world where public transit feels the heat from financial burdens, MV Transportation's recent move to support Mark Aesch for the Federal Transit Administration's top spot isn’t just a nod of approval—it's a full-blown trumpet blast. They're not just doling out a basic endorsement here; they're practically waving...

Continue Reading
BETR's Slide: Investors Face Big Losses, Leadership Shift

Updated Category News Views 113

BETR Investors Left in the Lurch It's a real trainwreck, folks. Better Home & Finance Holding Company, trading under NASDAQ:BETR, is in the spotlight for all the wrong reasons. The company expanded the class period for its investor lawsuit to include even more dates between March and August 2026, reflecting a torturous ride for shareholders. Their stock cratered by a...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 223

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
LaserAway Expands to 244 Clinics Over 20 Years

Updated Category News Views 186

A Milestone in Aesthetic Dermatology Twenty years, folks. That's a long haul for most businesses, let alone one in the fickle field of aesthetic dermatology. LaserAway, the juggernaut in this arena, has just opened its 244th clinic at 6300 Kingery Hwy in Willowbrook, IL. Nothing to be sneezed at. Imagine running a business, let alone one that's been amping up aesthetic...

Continue Reading
Webull Faces Class Action: Key Details for Investors

Updated Category News Views 170

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 166

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading

Top 5 Most Recently Viewed Articles

Hofseth BioCare ASA Secures Funding Through Private Placement

Updated Category News Views 216

Hofseth BioCare ASA Successfully Completes a Private Placement Hofseth BioCare ASA, often referred to as HBC, has recently completed a significant private placement aimed at enhancing its growth capital and strengthening its corporate balance sheet. This strategic move is set to fund the company's ongoing developments and initiatives effectively. The Details of the...

Continue Reading
Prosus N.V. Announces Limit for Tender Offer Notes

Updated Category News Views 78

The Brass Tacks of Prosus's Recent Move Today, Prosus N.V. put a definitive cap on its cash tender offer, inviting investors to sell back their notes due in 2027. What’s happening under this financial tablecloth? We’re diving into a U.S.$1,035,854,000 cap on the tendered notes—shaved down from their new senior notes total of U.S.$1,650,000,000. Decoding the Offer:...

Continue Reading
Growth Potential of the Asia Pacific Conference Room Solutions Market

Updated Category News Views 119

Understanding the Growth in the Asia Pacific Conference Room Solutions Market The Asia Pacific conference room solutions market is on a remarkable growth trajectory, with valuations surging from US$ 300.08 million in 2023 to a stunning US$ 1,922.25 million projected by 2032, at a compound annual growth rate (CAGR) of 23.79%. This surge can be attributed to several...

Continue Reading
BexBack Launches High-Leverage Trading with Exciting Bonuses

Updated Category News Views 176

Exciting New Trading Features from BexBack BexBack, a leading cryptocurrency exchange platform, is thrilled to reveal its latest trading enhancements, designed for traders eager to amplify their market position. These innovative features are now accessible to users across the globe, marking a significant step in meeting the soaring demand for high-leverage crypto trading....

Continue Reading
NexGen Health Achieves Milestone with Stellar Customer Reviews

Updated Category News Views 200

NexGen Health Celebrate Customer Satisfaction Milestone Leading Silicon Valley wellness clinic's exceptional patient reviews emphasize their commitment to cutting-edge IV therapy, personalized care, and innovative health solutions. NexGen Health, Silicon Valley's premiere wellness and anti-aging clinic, proudly announces a significant customer satisfaction milestone with...

Continue Reading